Open access
Open access
Powered by Google Translator Translator

Daily Archives: May 1, 2020

Classification of the Cutaneous Manifestations of COVID‐19 with 375 Illustrative Cases

1 May, 2020 | 03:43h | UTC

Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases – British Journal of Dermatology

Related: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology

Great atlas with the different cutaneous manifestations of Covid-19.

 


CO-RADS – A Categorical CT Assessment Scheme for Patients with Suspected COVID-19

1 May, 2020 | 03:48h | UTC

CO-RADS – A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation – Radiology

 


New CDC Guidance: Care for Breastfeeding Women with Covid-19

1 May, 2020 | 03:53h | UTC

Care for Breastfeeding Women – Centers for Disease Control and Prevention

 


Study Estimates the Impact of Social Distancing and School Closures on the Dynamics of the COVID-19 Outbreak

1 May, 2020 | 03:39h | UTC

Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China – Science

 

Related Commentary on Twitter

 


Study: Within 19 Days After Symptom Onset, 100% of Patients Test Positive for IGG

1 May, 2020 | 03:33h | UTC

Antibody responses to SARS-CoV-2 in patients with COVID-19 – Nature Medicine

Commentary: Expert reaction to antibody response in COVID-19 patients – Science Media Centre

 


Preprint Study Suggests Children May Be as Infectious as Adults

1 May, 2020 | 03:36h | UTC

An analysis of SARS-CoV-2 viral load by patient age – German Research network Zoonotic Infectious Diseases

Commentary: Expert reaction to a preprint looking at the amount of virus from those with COVID-19 in different age groups – Science Media Centre

 


Small Observational Study Suggests Prophylactic LMWH Can Prevent COVID‐19 Disseminated Intravascular Coagulopathy

1 May, 2020 | 03:26h | UTC

COVID‐19 Coagulopathy in Caucasian patients – British Journal of Haematology

Commentary: Blood clotting a significant cause of death in patients with COVID-19 – RCSI University of Medicine and Health Sciences

 


Treatment Considerations for COVID-19: A Critical Review of the Evidence

1 May, 2020 | 03:20h | UTC

Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof) – Mayo Clinic Proceedings

 


New Model to Track Covid-19 Spread

1 May, 2020 | 03:29h | UTC

Population flow drives spatio-temporal distribution of COVID-19 in China – Nature

Commentary: Researchers devise new model to track COVID-19’s spread – Yale News

 


[Abstract Only] Cohort Study: Effect of Hydroxychloroquine and Azithromycin on the QT Interval in Patients with Covid-19

1 May, 2020 | 03:10h | UTC

The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection – Circulation: Arrhythmia and Electrophysiology (link to abstract – $ for full-text)

 


COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options

1 May, 2020 | 03:18h | UTC

COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options – Cardiovascular Research

Related Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology

 


Perspective: Urging Caution on Remdesivir

1 May, 2020 | 03:07h | UTC

Urging Caution On Remdesivir – Forbes

Related: About Remdesivir and About “Game-Changers” – Science Translational Medicine AND Conflicting Remdesivir Trial Results Released; Experts Urge More Research – Health Policy Watch AND Is remdesivir a miracle drug to cure coronavirus? Don’t get your hopes up yet – The Conversation AND PulmCrit- First placebo-controlled RCT on remdesivir for COVID-19 – PulmCrit AND Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work? – The Guardian

“While I have enormous respect for the Institutes and their leaders, releasing the preliminary news without sharing the data behind it is highly irresponsible.”

 


Review: Neurologic Comorbidities and Complications in Patients Hospitalized for COVID-19

1 May, 2020 | 03:03h | UTC

Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 – Neurology

Related Studies: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries)

 


COVID-19: ICU Delirium Management During SARS-CoV-2 Pandemic

1 May, 2020 | 02:54h | UTC

COVID-19: ICU delirium management during SARS-CoV-2 pandemic – Critical Care

 


ACR Guidance for the Management of Patients with Rheumatic Disease During the COVID‐19 Pandemic

1 May, 2020 | 02:42h | UTC

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic – Arthritis & Rheumatism

Related Guideline: Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic – Annals of Rheumatic Diseases

 


We Need to Flatten the ‘Other’ Coronavirus Curve, Our Looming Mental Health Crisis

1 May, 2020 | 02:45h | UTC

We need to flatten the ‘other’ coronavirus curve, our looming mental health crisis – The Conversation

Related: Health Care Workers Seek to Flatten COVID-19’s ‘Second Curve’—Their Rising Mental Anguish

 


Clinical Determinants for Fatality of 44,672 Patients with COVID-19

1 May, 2020 | 02:48h | UTC

Clinical determinants for fatality of 44,672 patients with COVID-19 – Critical Care

 


AAN Recommendations for Closure of Patent Foramen Ovale in Secondary Stroke Prevention

1 May, 2020 | 02:34h | UTC

Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology

News Release: AAN updates recommendation on closure of common heart defect after stroke – American Academy of Neurology

 


Systematic Review: No Evidence to Support the Use of Aspirin for the Prevention of Dementia

1 May, 2020 | 02:38h | UTC

Aspirin and other non‐steroidal anti‐inflammatory drugs for the prevention of dementia – Cochrane Library

Summary: Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia – Cochrane Library

Related Randomized Trial: Aspirin Not Beneficial for Reducing the Risk of Dementia, MCI, or Cognitive Decline

 


Fri May 01 – 10 Stories of The Day!

1 May, 2020 | 03:58h | UTC

 

1 – Care for Breastfeeding Women – Centers for Disease Control and Prevention

 

2 – CO-RADS – A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation – Radiology

 

3 – Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases – British Journal of Dermatology

Related: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology

Great atlas with the different cutaneous manifestations of Covid-19.

 

4 – Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China – Science

 

5 – An analysis of SARS-CoV-2 viral load by patient age – German Research network Zoonotic Infectious Diseases

Commentary: Expert reaction to a preprint looking at the amount of virus from those with COVID-19 in different age groups – Science Media Centre

 

6 – Antibody responses to SARS-CoV-2 in patients with COVID-19 – Nature Medicine

Commentary: Expert reaction to antibody response in COVID-19 patients – Science Media Centre

 

7 – Population flow drives spatio-temporal distribution of COVID-19 in China – Nature

Commentary: Researchers devise new model to track COVID-19’s spread – Yale News

 

8 – COVID‐19 Coagulopathy in Caucasian patients – British Journal of Haematology

Commentary: Blood clotting a significant cause of death in patients with COVID-19 – RCSI University of Medicine and Health Sciences

 

9 – Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof) – Mayo Clinic Proceedings

 

10 – Coronavirus Disease (COVID-19) Updates / 01 May 2020 Edition

01 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.